Eton Pharmaceuticals is a pharmaceutical company. Co.'s product portfolio is comprised of three categories: Orphan Drugs, which include Alkindi Sprinkle® (hydrocortisone granules), a granule hydrocortisone formulation for the treatment of Adrenocortical Insufficiency designed for use in children; Hospital Products, which include Biorphen® (phenylephrine HCl) that is indicated for the treatment of hypotension resulting primarily from vasodilation in the setting of anesthesia; and Royalty Products, which include Alaway® Preservative Free (ketotifen fumarate), a preservative-free ophthalmic product approved for the treatment of allergic conjunctivitis. The ETON YTD return is shown above.
The YTD Return on the ETON YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether ETON YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the ETON YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.
|